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Abbreviations 
AF: atrial fibrillation 
BITA: bilateral internal thoracic arteries  
BMI: Body Mass Index 
CABG: coronary artery bypass grafting  
COPD: chronic obstructive pulmonary disease 
CX: Circumflex artery  
GLMM: Generalized linear mixed-effects model 
IABP: intraaortic balloon pump 
MAG: multiple arterial grafting  
MI: myocardial infarction 
NYHA: New York Heart Association 
LAD: left anterior descending artery  
LMD: left main disease 
LVEF: left ventricular ejection fraction 
PCI: percutaneous coronary intervention 
PVD: peripheral vascular disease 
RA: radial artery  
RCA: right coronary artery  
RRT: renal replacement tharapy 
sCr: serum creatinine 
SV: saphenous vein 
SW: sternal wound 
NVD: number of vessel disease 
LITA: left internal thoracic artery  
  
Central message: A nineteen years training experience at a single institution found, that 
adequately supervised trainees can perform CABG with multiple arterial grafting without 
compromising patient safety and long term survival. 
  
  
Perspective statement: The conflict between trainee education and patient safety, requires 
surgical training policies to be guided by robust clinical data and high-level evidence. We 
demonstrated that supervised trainees can effectively perform CABG with multiple arterial 
grafting without compromising patient safety. These results are expected to promote residents 
training in multiple arterial grafting.   
  
Abstract 
Objective: The learning curve of coronary artery bypass grafting (CABG) with multiple 
arterial grafting (MAG) is perceived to be associated with increased surgical morbidity and 
potentially poorer long term outcomes. We compared short term outcomes and long term 
survival in patients who underwent CABG with MAG performed by attending surgeons or 
resident trainees at a single institution over a period of 19 years. 
Methods: Using our institutional database, we identified 3039 patients undergoing MAG from 
1996 to 2015. Of those, 958 (32%) were operated by residents and 2081 (68%) by attending 
surgeons. Propensity score matching and mixed effect models were used to compare the two 
groups. 
Results: Operative mortality was 0.3% and 0.4% among patients operated by residents and 
attending surgeons respectively (P=0.71) with no significant differences between the groups in 
postoperative complications. After a mean follow-up time of 11±4 years, survival 
probability at 5,10 and 15 years was 95.1%±0.7% versus 96.4%±0.6%, 87.0%±1.1% 
versus 87.8%±1.1% and 76.6.%±1.8% versus 77.6%±1.8% in the resident and attending 
surgeon group respectively. Resident and attending surgeon cases showed comparable 
risk of death (HR 1.01; 95%CI 0.80-1.28; P=0.92). The equipoise between the two groups 
was confirmed among cases receiving bilateral internal thoracic arteries only (HR 0.88; 
95%CI 0.54-1.43; P=0.61), radial artery (HR 1.22; 95%CI 0.92-1.61; P=0.15) or their 
combination (HR 0.74; 95%CI 0.33-1.65; P=0.47).  
Conclusions: The present analysis confirms that adequately supervised trainees can perform 
CABG with multiple arterial grafting without compromising patient safety and long term 
survival. 
Word count: 242 
  
Despite multiple arterial grafting (MAG) including bilateral internal thoracic arteries (BITA) 
and radial artery (RA) has been consistently shown to improve survival after coronary artery 
bypass grafting (CABG), it still remains largely underutilized [1-4]. It is disconcerting that only 
10% of patients undergoing CABG currently receive a second arterial graft in the United States, 
approximately 4% with BITA and 6% with RA [5]. Moreover, among 1541 procedures 
performed in the SYNTAX trial and registry, 97.1% included a single arterial conduit, while 
only 22.7% received BITA grafts [6].  
The most commonly cited reason for not performing CABG with MAG, is the learning curve, 
perceived to be associated with increased surgical morbidity and potentially poorer long term 
outcomes [7]. This often result in lack of exposure to MAG procedures during cardiothoracic 
training program [7]. Moreover, the current intense professional and public scrutiny of cardiac 
surgeons’ results creates a hostile environment not conducive to trainees’ exposure to MAG. 
Here, we compared the short and long term outcomes of CABG with MAG performed by 
attending surgeons or resident trainees at the Bristol Heart Institute over a period of 19 years.  
  
Methods 
Study design 
The study was conducted in accordance with the principles of the Declaration of Helsinki. The 
local audit committee approved the study, and the requirement for individual patient consent 
was waived. This study was a registry-based analysis involving patients with multivessel 
coronary artery disease who underwent elective isolated CABG using at least two arterial 
conduits from April 1996 to April 2015, at the Bristol Heart Institute, United Kingdom. We 
retrospectively analysed prospectively collected data from the National Institute for 
Cardiovascular Outcomes Research (NICOR) registry for audit and quality assessment of adult 
cardiac surgery in the United Kingdom. Reproducible cleaning algorithms were applied to the 
database, which are regularly updated as required. Briefly, duplicate records and non-adult 
cardiac surgery entries were removed; transcriptional discrepancies harmonized; and clinical 
conflicts and extreme values corrected or removed. The data are returned regularly to the local 
units for validation. Further details and definition of variables are available at 
http://www.ucl.ac.uk/nicor/audits/adultcardiac/datasets.  
Study population 
Patients were eligible for inclusion in the study if they had undergone isolated CABG 
performed by either attending surgeons or residents using at least two arterial conduits in the 
following configuration: BITA, left internal thoracic artery (LITA) and RA or BITA plus RA 
with or without additional saphenous vein (SV) grafts. In the present series, the RA was 
considered only in case of target stenosis ≥75% and it was used as a free graft proximally 
connected to the ascending aorta or as a “y “graft attached to the internal thoracic artery. The 
internal thoracic artery was used as a pedicle graft that remained proximally connected to its 
respective subclavian artery (in situ) or as a free graft proximally connected to other internal 
thoracic artery as a “y” graft. Exclusion criteria were: 1) cases performed by non-attending 
  
surgeons who had completed their training program; 2) no information available on the 
primary surgeon status; and 3) LITA not used.  
 
Training Program 
The Bristol Heart Institute is a regional cardiac surgical center and part of the UK 
national training program. The UK cardiothoracic training program is conducted over a 
6-year period, and admission to it requires successful completion of a 2-year basic 
surgical training program. Two to three National Training Numbers were allocated to 
our unit at any time during the study period. In addition, 4 to 6 clinical research or service 
clinical fellows completed the surgical rota. Seniority level of trainees with official 
training numbers was defined according to year of training in the UK specialist program 
in cardiothoracic surgery (Calman year 1–6). For trainees who did not have an official 
UK training number (research or clinical fellows), the level of experience was reviewed 
and assigned according to equivalent criteria. A resident case was retrospectively defined 
as a case in which the cardiothoracic resident performed the entire surgical procedure. A 
supervised operation performed by a resident was defined as one in which the attending 
surgeon was scrubbed in and acted as first assistant. An unsupervised operation was 
defined as one in which the resident had reviewed the case and planned the surgical 
strategy with the attending surgeon who was not scrubbed in. The decision to have a 
resident case was at the discretion of individual attending surgeons. There was no formal 
agreement on a minimum number of cases to be performed by the resident during his/her 
training program. The patients operated upon by the resident were selected by assessing 
their suitability for training taking into account the urgency of the operation and their 
co-morbidities, the quality of the coronary arteries and the number of grafts required. 
  
Training in MAG progressed to gradually increasing levels of complexity including y 
graft and off-pump multiple arterial grafting.  
Study Endpoints 
Short-term outcomes analysed were: re-exploration for bleeding, need for sternal wound 
reconstruction, postoperative cerebrovascular accident (CVA) (defined as any confirmed 
neurologic deficit of abrupt onset that did not resolve within 24 hours), postoperative 
renal replacement therapy (RRT), need for postoperative intra-aortic balloon pump 
(IABP), in-hospital mortality, the occurrence of any of above complications and length of 
stay was compared between the two groups. The incidence of incomplete 
revascularization (IR), defined as at least one diseased primary arterial territory not 
grafted was also investigated. 
Long term outcome investigated was all-cause mortality. This is considered the most 
robust and unbiased index in cardiovascular research because no adjudication is 
required, thus avoiding inaccurate or biased documentation and clinical assessments [9]. 
Information about post-discharge mortality tracking was available for all patients 
(100%) and was obtained by linking the institutional database with the National General 
Register Office.  
Pre-treatment variables 
The effect of procedure performed by Resident versus Attending  surgeon on outcomes 
of interest was adjusted for the following pre-treatment variables including: age, 
gender, body mass index (BMI); New York Heart Association grade III or IV; prior 
myocardial infarction (MI) within 30 days, previous percutaneous coronary 
intervention (PCI); active smoking; diabetes mellitus (DM) on oral treatment or on 
insulin; chronic obstructive pulmonary disease (COPD); current smoking; serum 
creatinine ≥200 mmol/l, previous cerebrovascular accident (CVA); peripheral vascular 
  
disease (PVD); preoperative atrial fibrillation (AF); left main disease (LMD); number 
of vessel diseased; left ventricular ejection fraction (LVEF) between 30% and 49%; 
LVEF less than 30%; non elective admission, emergent/salvage operation; cardiogenic 
shock; preoperative IABP and eras of surgery. Predicted risk was assessed using 
Euroscore according to the following definition [10]: low risk as 0-2 points (0.8% 
expected mortality), medium risk as 3-5 points (3.0% expected mortality), and high risk 
as > 5 points (11% expected mortality)  
 
Statistical analysis 
Categorical variables were presented as frequencies and percentages and continuous variables 
were expressed as mean±standard deviation. Multiple imputation was used to address missing 
data (https://cran.r-project.org/package=Amelia). Rubin's method [11] was used to combine 
results from each of 3 imputed data sets. To control for measured potential confounders in the 
data set, a propensity score (PS) was generated for each patient from a multivariable logistic 
regression model based on pre-treatment covariates as independent variables with procedure 
performed by resident versus attending surgeon as a binary dependent variable [12] 
(Supplementary Table 1). Pairs of patients operated by resident versus attending surgeon were 
derived using greedy 1:1 matching with a calliper of width of 0.2 standard deviation of the logit 
of the PS (http://CRAN.Rproject.org/package=nonrandom). The quality of the match was 
assessed by comparing selected pre-treatment variables in propensity score– matched patients 
using the standardized mean difference (SMD), by which an absolute standardized difference 
of greater than 10% is suggested to represent meaningful covariate imbalance. To account for 
the hierarchical clustering of cases by resident and attending pairs, generalized mixed 
models were used whereas random intercepts for matching sets were modeled. 
Generalized linear mixed-effects model was used for short term outcomes. (https://cran.r-
  
project.org/package=lme4) was used for short term outcomes. Mixed effect Cox 
regression was used to investigate the treatment effect on survival (https://CRAN.R-
project.org/package=coxme). Time-segmented analysis was used to account for different 
hazard phases during follow-up [13]. The hazard function was used as a guide to 
determine approximate time points for the end of the early hazard phase and the 
beginning of the late phase (http://CRAN.R-project.org/package=muhaz). To account for 
individual attending surgeon effect on outcomes and resident case selection (certain 
attending surgeons were more likely to allow residents to perform MAG procedures), a 
second random effect including attending surgeon identification number was added to 
the model. The intercept for random effect (excess risk) was estimate by using its standard 
deviation. Integrated log likelihood test was used to test the random effect. Subgroup 
analysis was also conducted according to arterial graft configuration adopted (BITA or RA 
grafting separately). Finally the effect of procedure performed by resident versus attending on 
in-hospital mortality and late mortality was investigated according to different stages of 
cardiothoracic training program early stage (year 1 and 2), intermediate stage (years 3 and 4), 
final stage (years 5 and 6). Unsupervised and supervised cases were also compared. All p-
values <0.05 were considered to indicate statistical significance. All statistical analysis was 
performed using R Statistical Software (version 3.2.3; R Foundation for Statistical Computing, 
Vienna, Austria). 
Results 
Study population 
We identified 3039 patients for the final analysis who underwent isolated CABG with MAG 
during the study period (Supplementary Figure 1). Of those, 958 (32%) were operated by 
residents and 2081 (68%) by attending surgeons. A total of 22 attending surgeons were 
identified during the study period. There was a large variability in number of MAG cases 
  
performed by individual attending surgeons and relative rate of resident cases 
(Supplementary Table 2). Identification of residents performing the procedure was not 
reported in the majority of cases (735, 76%). Information regarding the stage of training 
program was available for 340/958(35%) resident cases (early=21; intermediate =128; 
final =191). Information regarding the supervision by attending surgeon was available 
for 395/958(41%) resident cases with 338 supervised and 57 unsupervised resident cases. 
Among unsupervised resident cases, 48 were performed by a resident at final stage of 
training and 3 by a resident at intermediate stage of training.  
Patients characteristics distribution before and after PS matching are summarized in 
Table 1. Overall, attending surgeons operated on patients with a higher burden of 
comorbidities and more likely to have 3 vessel disease and left main disease. Moreover, 
resident cases were more likely to be performed during the early years (Figure 1). Burden 
of comorbidities and gradually increased over the time with a concomitant decrease in 
number of cases performed by residents. (Supplementary Table 3). A similar trend was 
also observed in non-MAG cases (Supplementary Figure 2).  After PS matching, 958 
matched pairs were obtained and the two groups were comparable for all pre-treatment 
variables including the extension of coronary artery disease (SMD<10%, Figure 2).  
Intraoperative data.  
Intraoperative data in the matched groups is reported in Table 2. Resident cases received 
the same number of grafts and the incidence of incomplete revascularization was 
comparable between the two groups. Rate of off-pump surgery was higher among 
attending surgeon cases and x-clamp time and cardiopulmonary bypass time was higher 
among resident cases. Arterial grafts configuration was also different between the two 
groups: BITA usage was higher among resident cases while RA usage was higher among 
attending surgeon cases.   
  
Operative outcomes 
Table 3 summarizes postoperative outcomes in the matched cohort. No significant 
differences were observed between the two groups. The 3 deaths in the resident group all 
occurred in patients receiving the RA as additional conduit to the ITA. In two cases, off-
pump surgery was performed. One death occurred with an unsupervised resident at last-
stage of training program, the second death occurred with a supervised resident at final-
stage and in one case information on resident status was not available.  
Survival 
In the matched cohort, mean follow-up time was 11±4 years. Survival probability at 5,10 
and 15 years was 95.1%±0.7% versus 96.4%±0.6%, 87.0%±1.1% versus 87.8%±1.1% 
and 76.6.%±1.8% versus 77.6%±1.8% in the resident and attending surgeon group 
respectively (Figure 3). The instantaneous risk of death (the hazard function) was found 
to have 2 hazard phases. The first was a declining hazard phase from the time of operation 
throughout nearly the first 30 months (early hazard).  It then gave way to an increasing 
hazard phase beyond 30 months (late hazard, Supplementary Figure 3). Resident and 
Attending surgeon cases showed comparable risk of death during both the early (HR 
1.24; 95%CI 0.64-2.42; P=0.50) and the late phase (HR 1.01; 95%CI 0.80-1.28; P=0.92). 
When the clustering effect due to individual surgeon was added to the model, the two 
groups were still comparable in terms of early (HR 1. 22: 95%CI 0.63-2.38; P=0.57) and 
late (HR 1. 04: 95%CI 0.80-1.33; P=0.79). The excess risk for each attending surgeon (the 
random effect) had a standard deviation of 0.40 and 0.47 for early and late phase (P=1 
and P=0.003). Therefore ~15% of attending surgeons had the risk late death of 1.6 times 
the norm and a similar fraction had lower risk thus suggesting a modestly large attending 
surgeon effect.  
  
Resident cases were not associated with higher risk of late death in case of early stage of 
training (HR 1.11; 95%CI 0.27-4.67; P=0.88), intermediate stage (HR 0.78;95%CI 0.41-
1.48; P=0.45) and final stage (HR 1.20;95%CI 0.72-2.01; P=0.47; Figure 4).  Finally, the 
equipoise of survival rates between the two groups persisted when we included either 
supervised (HR 1.05; 95%CI 0.70-1.59; P=0.79) or unsupervised (HR 0.81; 95%CI 0.30-
2.19; P=0.68; Figure 5) cases. The equipoise between the two groups in terms of late 
mortality was confirmed among cases receiving BITA only (HR 0.88; 95%CI 0.54-1.43; 
P=0.61), LITA plus RA (HR 1.22; 95%CI 0.92-1.61; P=0.15) or the combination of BITA 
and RA grafting (HR 0.74; 95%CI 0.33-1.65; P=0.47) and among off-pump (HR 1.13; 
95%CI 0.83-1.55; P=0.42) and on pump (HR 0.96; 95%CI 0.70-1.37; Figure 5).  Finally 
the two groups presented similar late survival when the analysis was stratified according 
to low risk (Euroscore 0-2: HR 0.96; 95%CI0.69-1.34; P=0.84), intermediate risk 
(Euroscore 3-5: HR 0.96; 95%CI 0.67-1.36; P=0.82) and high risk (Euroscore 6 plus: HR 
0.94; 95%CI 0.48-1.83; P=0.87; Figure 5).  
Discussion 
The main finding of this study was that MAG can be safely performed by cardiac surgical 
residents.  Early morbidity was particularly and survival rate up to 15 years were 
comparable to those observed in patients operated by attending surgeons.  
Although the use of additional arterial grafts has been shown to be associated with better 
outcomes including prolonged survival [1-4], CABG with MAG remains underutilized [5,6]. 
The learning curve has been cited as the most common reason for not performing MAG [6], 
questioning whether this procedure should be at all part of a cardiothoracic training program. 
Performing MAG is undoubtedly technically demanding and patient’s safety should always be 
a concern when training young surgeons. The effect of training on clinical outcome after 
  
cardiac surgery has been the subject of previous publications [14-17]. However, to the best of 
our knowledge, this is the first study which compared outcomes in patients undergoing CABG 
with MAG performed by residents versus attending surgeons and we found that the two 
groups had comparable short term outcomes and long term survival. We noticed that 
residents were more likely to use BITA while the use of RA was more common among 
cases performed by attending surgeons. This difference may be partially explained by the 
better quality of coronary anatomy of resident cases more suitable for BITA grafting. 
Unfortunately information regarding the quality of native coronary arteries was not 
available in this retrospective study. However, our subgroup analysis confirmed the 
equipoise between residents and attending surgeons in performing MAG regardless the 
graft selection. MAG performed by resident was also shown to be safe during both on pump 
and off pump procedures. Finally stage of training program did not significantly impact of late 
survival. However, it should be noted that in UK, the training program in cardiothoracic surgery 
is preceded by a surgical core program which provides basic surgical skills training. In the 
present analysis, there were only few cases performed by resident without supervision and we 
cannot draw any final conclusion. In many institutions, trainees are preferentially allocated 
lower-risk and non-urgent CABG cases, so as not to compromise patient safety [18]. The same 
trend was found in the present analysis and the increase in patient risk profile in more recent 
years translate into a lower relative volume of resident cases. However, subgroup analysis 
based on Euroscore risk classes confirmed that resident and attending surgeons were 
comparable in performing MAG regardless patient risk profile. Interestingly, using a 
mixed model we found a significant effect of individual attending surgeon on late 
mortality regardless the procedure was performed by resident or not. These findings 
support the hypothesis that other factors may contribute to the safety and efficacy 
demonstrated by residents such as quality of attending surgeon supervision [19]. Indeed, 
  
in their analysis of >4000 CABG procedures, Elbardissi and colleagues [20] found that the 
cumulative experience of a consultant-trainee pairing and their familiarity with one another 
were more significant predictors of operative outcomes than was individual surgeon 
experience. Similarly our findings support the hypothesis that trainees can safely perform 
CABG with MAG in the context of a well-structured training program and appropriate 
supervision. 
The present analysis has several limitations. First, it is a retrospective, observational report. 
Propensity technique can adjust only for measurable and included variables and we cannot 
exclude a selection bias based on non-measurable “eye-ball” in favour of cases performed by 
residents. Patients operated upon by the resident were selected by assessing their 
suitability for training taking into account not only the urgency of the operation and their 
comorbidities but also the quality of the coronary arteries. This information was not 
available for the present analysis. Furthermore, the training usually progresses to 
gradually increasing levels of complexity and responsibility according to the surgical 
abilities of the resident. The present analysis could not address whether or not the 
residents are truly trained on the procedures. Information regarding resident identity 
was largely missing and we could not analyse its random effect. We stratified our analysis 
according to stage of training but variation of ability and experience can occur within the 
same stage. Moreover, cases that were initially assigned to trainees may have required part of 
the procedure to be performed by the attending surgeon in the event of unexpected 
intraoperative complications or difficulties. Although this confounding could theoretically 
have biased our analysis toward a null value, it provides a more real-world clinical assessment 
of a surgical training program. To support our conclusions, we repeated the analysis in the 
cohort of non-MAG patients. By comparing 3556 matched pairs, we found that resident 
non-MAG cases were associated with comparable short-term outcomes (Supplementary 
  
Table 4) and survival when compared to non-MAG attending surgeon cases (HR 
0.85;95%CI 0.71-1.13; Supplementary Figure 4). 
In conclusion, the present analysis confirms that MAG exposure during residency is safe 
without compromising outcomes when adequately supervised by experienced attending 
surgeons. Hands-on experience in the operative setting is essential for trainees to develop both 
the technical skills and clinical judgment required to independently use multiple arterial 
conduits. Given the perceived conflict between trainees’ education and patient safety, it is 
imperative for surgical training policies to be guided by robust clinical data and high-level 
evidence.   
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Table 1. Baselines characteristics before and after propensity score matching  
                              
 
Resident 
 
Attending 
(all) 
 
SMD Attending 
(matched) 
 
SM
D 
Overall                        
 
958 
 
2081 
  
958 
  
Age <60 541 56.5% 998 48.0% -17% 522 54.5% 0% 
                              60-69 324 33.8% 762 36.6% 
 
338 35.3% 
 
                              70-79 89 9.3% 282 13.6% 
 
92 9.6% 
 
                               ≥80 4 0.4% 39 1.9% 
 
6 0.6% 
 
  
         
Female                        No 859 89.7% 1843 88.6% -4% 861 89.9% 1% 
                              Yes 99 10.3% 238 11.4% 
 
97 10.1% 
 
  
         
BMI <18.5 3 0.3% 4 0.2% -8% 3 0.3% -1% 
                              18.5-
24.9 
195 20.4% 417 20.0% 
 
198 20.7% 
 
                              25-29.9 488 50.9% 1017 48.9% 
 
483 50.4% 
 
                              30-34.9 230 24.0% 497 23.9% 
 
216 22.5% 
 
                              ≥35 42 4.4% 146 7.0% 
 
58 6.1% 
 
  
         
NYHA 
III-IV                          
No 742 77.5% 1618 77.8% 1% 743 77.6% 0% 
                              Yes 216 22.5% 463 22.2% 
 
215 22.4% 
 
  
         
MI within 
30 days        
No 844 88.1% 1713 82.3% 16% 846 88.3% 0% 
                              Yes 114 11.9% 368 17.7% 
 
112 11.7% 
 
  
         
PCI                           No 913 95.3% 1978 95.1% 1% 908 94.8% -2% 
                              Yes 45 4.7% 103 4.9% 
 
50 5.2% 
 
  
         
Smoking                       No 805 84.0% 1744 83.8% -1% 802 83.7% -1% 
                              Yes 153 16.0% 337 16.2% 
 
156 16.3% 
 
  
         
DM orally 
treated                           
No 886 92.5% 1912 91.9% 2% 887 92.6% 0% 
                              Yes 72 7.5% 169 8.1% 
 
71 7.4% 
 
  
         
DM on 
insulin                          
No 902 94.2% 1965 94.4% 1% 901 94.1% 0% 
                              Yes 56 5.8% 116 5.6% 
 
57 5.9% 
 
  
         
sCr≥200m
mol/l                         
No 953 99.5% 2065 99.2% -3% 952 99.4% -1% 
                              Yes 5 0.5% 16 0.8% 
 
6 0.6% 
 
  
  
         
COPD                          No 919 95.9% 1992 95.7% 1% 912 95.2% -4% 
                              Yes 39 4.1% 89 4.3% 
 
46 4.8% 
 
  
         
CVA                            No 939 98.0% 2025 97.3% -5% 940 98.1% 1% 
                              Yes 19 2.0% 56 2.7% 
 
18 1.9% 
 
  
         
PVD                           No 899 93.8% 1933 92.9% -4% 899 93.8% 0% 
                              Yes 59 6.2% 148 7.1% 
 
59 6.2% 
 
  
         
AF                            No 937 97.8% 2034 97.7% 0% 937 97.8% 0% 
                              Yes 21 2.2% 47 2.3% 
 
21 2.2% 
 
  
         
NVD                           1 21 2.2% 31 1.5% -13% 21 2.2% 1% 
                              2 320 33.4% 584 28.1% 
 
325 33.9% 
 
                              3 617 64.4% 1466 70.4% 
 
612 63.9% 
 
  
         
LMD                           No 754 78.7% 1547 74.3% -10% 742 77.5% -3% 
                              Yes 204 21.3% 534 25.7% 
 
216 22.5% 
 
  
         
LVEF 
30%-49%                    
No 839 87.6% 1700 81.7% -16% 832 86.8% -2% 
                               Yes 119 12.4% 381 18.3% 
 
126 13.2% 
 
  
         
LVEF 
<30%                      
No 953 99.5% 2029 97.5% -16% 954 99.6% 2% 
                              Yes 5 0.5% 52 2.5% 
 
4 0.4% 
 
  
         
Shock                         No 958 100.0% 2080 100.0% 3% 958 100.0% 0% 
  Yes 0 0.0% 1 0.0% 
 
0 0.0% 
 
  
         
Preop 
IABP                     
No 957 99.9% 2069 99.4% -8% 957 99.9% 1% 
                              Yes 1 0.1% 12 0.6% 
 
1 0.1% 
 
  
         
Non-
elective                  
No 592 61.8% 1176 56.5% -11% 568 59.3% -5% 
                              Yes 366 38.2% 905 43.5% 
 
390 40.7% 
 
  
         
Emergent/
salvage                      
No 957 99.9% 2064 99.2% -11% 957 99.9% 0% 
                              Yes 1 0.1% 17 0.8% 
 
1 0.1% 
 
  
         
Eras 1996-
1999 
254 26.5% 307 14.8% -41% 238 24.8% 1% 
  
                              2000-
2004 
374 39.0% 653 31.4% 
 
383 40.0% 
 
                              2005-
2009 
230 24.0% 797 38.3% 
 
258 26.9% 
 
                              2010-
2015 
100 10.4% 324 15.6% 
 
79 8.2% 
 
          
Euroscore  0-2 590 61.6% 1198 57.6%  620 64.7%  
  3-5 321 33.5% 699 33.6%   302 31.5%  
 6 plus 47 4.9% 184 8.8%  36 3.8%  
BMI: Body Mass Index; NYHA: New York Heart Association; MI: myocardial infarction; 
PCI: percutaneous coronary intervention; DM: diabetes mellitus; sCr: serum creatinine; 
COPD: chronic obstructive pulmonary disease; CVA: cerebrovascular accident; PVD: 
peripheral vascular disease; AF: atrial fibrillation; NVD: number of vessel disease; LMD: left 
main disease; LVEF: left ventricular ejection fraction; IABP: intraaortic balloon pump 
  
  
Table 2. Operative data in the matched cohort 
         
Resident 
(N=958) 
Attending 
(N=958) 
PGLMM 
  n % n %  
Number of grafts 2 350 36.5% 346 36.1% 0.32 
        3 471 49.2% 449 46.9%  
        4 128 13.4% 151 15.8%  
        5 9 0.9% 12 1.3%  
        
Incomplete 
Revascularization   
No 792 82.7% 777 81.1% 0.37 
        Yes 166 17.3% 181 18.9%  
        
LAD  grafted  No 20 2.1% 23 2.4% 0.46 
        Yes 938 97.9% 935 97.6%  
        
RCA  grafted   No 310 32.4% 314 32.8% 0.84 
        Yes 648 67.6% 644 67.2%  
        
CX  grafted    No 192 20.0% 206 21.5% 0.42 
        Yes 766 80.0% 752 78.5%  
        
OPCAB   No 489 51.0% 420 43.8% <0.001 
        Yes 469 49.0% 538 56.2%  
        
       
X-time min(mean,sd) 32±27 25±24 <0.001 
       
CPB-time min(mean,sd) 54±44 45±41 <0.001 
       
Graft configuration BITA 332 34.7% 221 23.1% <0.001 
  BITA+RA 91 9.5% 96 10.0%  
  RA 535 55.8% 641 66.9%  
GLMM: Generalized linear mixed-effects model; LAD: left anterior descending artery; RCA: 
right coronary artery; CX: circumflex artery; OPCAB: off-pump coronary artery bypass 
grafting; BITA: bilateral internal thoracic arteries; RA: radial artery  
  
Table 3. Postoperative outcomes in the matched cohort.  
         
 
Resident 
N=958 
Attending 
N=958 
PGLMM 
  
n % n % 
 
Re-exploration for bleeding  No 937 97.8% 935 97.6% 0.76 
        Yes 21 2.2% 23 2.4% 
 
  
      
SW reconstruction  No 956 99.8% 955 99.7% 0.65 
        Yes 2 0.2% 3 0.3% 
 
  
      
Postoperative CVA No 951 99.3% 953 99.5% 0.53 
        Yes 7 0.7% 5 0.5% 
 
  
      
Postoperative RRT No 949 99.1% 948 99.0% 0.82 
         Yes 9 0.9% 10 1.0% 
 
  
      
Postoperative IABP No 947 98.9% 947 98.9% 1 
        Yes 11 1.1% 11 1.1% 
 
  
      
In-hospital mortality No 955 99.7% 954 99.6% 0.71 
        Yes 3 0.3% 4 0.4% 
 
  
      
Any of above complication No 911 95.1% 908 94.8% 0.75 
        Yes 47 4.9% 50 5.2%  
       
Length of stay days(mean, sd) 6.9±4.3 
 
7.1±6.3 
 
0.8 
GLMM: Generalized linear mixed-effects model; SW: sternal wound; CVA cerebrovascular 
accident; RRT: renal replacement therapy; IABP: intraaortic balloon pump.   
  
Supplementary Table 1.  Variables included in the propensity score with relative effect size.  
Variable OR 95%CI LL 95%CI UL P-value 
Age* (for 1 year increase) 0.99 0.98 1.00 0.05 
Female  0.90 0.69 1.17 0.44 
BMI* (for 1 unit increase) 0.99 0.97 1.01 0.18 
NYHA III-IV 1.01 0.83 1.23 0.92 
MI within 30 days  1.03 0.79 1.34 0.80 
PCI  1.37 0.93 1.99 0.11 
smoking  0.92 0.73 1.15 0.46 
DM orally treated  1.10 0.82 1.49 0.51 
DM on insulin  1.18 0.83 1.67 0.35 
sCr>200 mmol/l 0.92 0.28 2.57 0.87 
COPD  1.28 0.84 1.90 0.23 
CVA  0.83 0.47 1.41 0.50 
PVD  0.93 0.67 1.29 0.66 
AF  1.26 0.72 2.15 0.40 
NVD  0.80 0.69 0.94 0.004 
LMD  0.90 0.74 1.09 0.28 
LVEF 30%-49% 0.61 0.48 0.76 <0.0001 
LVEF <30% 0.20 0.07 0.46 <0.0001 
Shock  0.00 - - 0.96 
Preop IABP  0.38 0.02 2.05 0.36 
Non-elective  0.87 0.73 1.04 0.12 
emergent  0.19 0.01 0.96 0.10 
Eras* (for 1 year increase)  0.91 0.89 0.93 <0.0001 
Entered as continuous variable. OR: Odds ratio; LL: lower limit; UL: upper limit; CI: 
confidence interval; BMI: Body Mass Index; NYHA: New York Heart Association; MI: 
myocardial infarction; PCI: percutaneous coronary intervention; DM: diabetes mellitus; sCr: 
serum creatinine; COPD: chronic obstructive pulmonary disease; CVA: cerebrovascular 
accident; PVD: peripheral vascular disease; AF: atrial fibrillation; NVD: number of vessel 
disease; LMD: left main disease; LVEF: left ventricular ejection fraction; IABP: intraaortic 
balloon pump  
  
Supplementary Table 2. Attending surgeon with number of multiple arterial grafting 
procedures performed and relative percentage of resident cases  
Attending 
Surgeon 
Total 1996-2004 2005-2015 
N=3039 N=1588 N=1451 
  n 
% by 
Resident 
 n 
 % by 
Resident 
n  
% by 
Resident  
#1 37 35% 37 35% 0   
#2 817 39% 586 39% 231 38.5% 
#3 340 36% 236 40% 104 26.0% 
#4 388 44% 279 49% 109 30.3% 
#5 4 0% 4 0% 0   
#6 103 51% 102 50% 1 100.0% 
#7 26 12% 8 0% 18 16.7% 
#8 43 79% 43 79% 0   
#9 23 4%     23 4.3% 
#10 245 46% 120 48% 125 44.0% 
#11 8 13% 8 12% 0   
#12 275 22%     275 21.5% 
#13 119 14% 28 21% 91 12.1% 
#14 274 8%     274 8.0% 
#15 49 14% 49 14% 0   
#16 246 10% 86 0% 160 15.0% 
#17 3 0%     3 0.0% 
#18 16 31%     16 31.2% 
#19 5 0%     5 0.0% 
#20 1 0%     1 0.0% 
#21 8 0%     8 0.0% 
#22 7 0%     7 0.0% 
Missing 2 0% 2 0% 0   
   
  
Supplementary Table 3. Baseline characteristics across different eras with relative percentage of resident cases.  1 
                                         1996-1999 2000-2004 2005-2009 2010-2015 X2 
against 
Eras 
    n % % by 
Resident 
n % % by 
Resident 
n % % by 
Resident 
n % % by 
Resident 
  
Total                            561 
 
45% 1027   36% 1027   22% 424   24% <0.001 
Age <60 391 70% 44% 549 53% 37% 419 41% 26% 180 42% 33% <0.001 
                              60-69 150 27% 49% 382 37% 36% 421 41% 20% 133 31% 21%   
                              70-79 20 4% 40% 96 9% 34% 167 16% 23% 88 21% 11%   
                              ≥80 0 0% 
 
0 0%   20 2% 10% 23 5% 9%   
    
 
0% 
 
  0%     0%     0%     
Female                        No         511 91% 46% 904 88% 36% 915 89% 22% 372 88% 25% 0.2 
                              Yes        50 9% 38% 123 12% 37% 112 11% 25% 52 12% 14%   
    
 
0% 
 
  0%     0%     0%     
BMI <18.5 2 0% 50% 2 0% 50% 3 0% 33% 0 0%   <0.001 
                              18.5-
24.9 
108 19% 40% 221 22% 38% 195 19% 24% 88 21% 23%   
                              25-29.9 341 61% 47% 497 48% 36% 493 48% 22% 174 41% 26%   
                              30-34.9 98 17% 49% 247 24% 37% 247 24% 25% 135 32% 22%   
                              ≥35 12 2% 25% 60 6% 33% 89 9% 16% 27 6% 19%   
    
 
0% 
 
  0%     0%     0%     
NYHA  III-IV                         No 423 75% 46% 743 72% 35% 831 81% 23% 363 86% 25% <0.001 
                              Yes        138 25% 43% 284 28% 39% 196 19% 18% 61 14% 15%   
    
 
0% 
 
  0%     0%     0%     
MI within 30 
days                       
No         540 96% 46% 952 93% 36% 801 78% 23% 264 62% 26% <0.001 
                              Yes        21 4% 38% 75 7% 36% 226 22% 21% 160 38% 19%   
    
 
0% 
 
  0%     0%     0%     
  
PCI                           0 561 100% 45% 1003 98% 37% 959 93% 21% 368 87% 23% <0.001 
    
 
0% 
 
24 2% 12% 68 7% 37% 56 13% 30%   
    
 
0% 
 
  0%     0%     0%     
smoking                       No         455 81% 47% 851 83% 36% 883 86% 22% 360 85% 24% 0.05 
                              Yes        106 19% 40% 176 17% 38% 144 14% 22% 64 15% 20%   
    
 
0% 
 
  0%     0%     0%     
DM orally treated                           No         534 95% 46% 952 93% 37% 928 90% 22% 384 91% 23% 0.004 
                              Yes         27 5% 41% 75 7% 35% 99 10% 25% 40 9% 25%   
    
 
0% 
 
  0%     0%     0%     
DM on insulin                         No 538 96% 46% 963 94% 36% 964 94% 22% 402 95% 24% 0.3 
                              Yes        23 4% 39% 64 6% 44% 63 6% 27% 22 5% 9%   
    
 
0% 
 
  0%     0%     0%     
sCr≥200mmol/l                         No 557 99% 46% 1025 100% 36% 1025 100% 22% 411 97% 23% <0.001 
                              Yes        4 1% 0% 2 0% 50% 2 0% 0% 13 3% 31%   
    
 
0% 
 
  0%     0%     0%     
COPD                          No         549 98% 46% 1001 97% 36% 971 95% 23% 390 92% 23% <0.001 
                              Yes        12 2% 25% 26 3% 62% 56 5% 16% 34 8% 32%   
    
 
0% 
 
  0%     0%     0%     
CVA                            No         551 98% 46% 1008 98% 36% 992 97% 23% 413 97% 24% 0.09 
                              Yes        10 2% 30% 19 2% 63% 35 3% 6% 11 3% 18%   
    
 
0% 
 
  0%     0%     0%     
PVD                           No         528 94% 45% 951 93% 37% 967 94% 23% 386 91% 24% 0.1 
                              Yes        33 6% 58% 76 7% 33% 60 6% 15% 38 9% 16%   
    
 
0% 
 
  0%     0%     0%     
AF                            No         555 99% 45% 1005 98% 36% 1000 97% 22% 411 97% 24% 0.1 
                              Yes        6 1% 50% 22 2% 36% 27 3% 26% 13 3% 23%   
    
 
0% 
 
  0%     0%     0%     
NVD                           1VD 8 1% 38% 13 1% 31% 22 2% 55% 9 2% 22% 0.006 
                               2VD 165 29% 44% 356 35% 39% 260 25% 24% 123 29% 37%   
  
                              3VD 388 69% 46% 658 64% 35% 745 73% 21% 292 69% 18%   
    
 
0% 
 
  0%     0%     0%     
LMD                           No         482 86% 46% 779 76% 37% 756 74% 23% 284 67% 24% <0.001 
                              Yes        79 14% 41% 248 24% 33% 271 26% 21% 140 33% 22%   
    
 
0% 
 
  0%     0%     0%     
LVEF 30-49% No         473 84% 48% 838 82% 38% 862 84% 23% 366 86% 25% 0.1 
                              Yes        88 16% 32% 189 18% 30% 165 16% 17% 58 14% 12%   
    
 
0% 
 
  0%     0%     0%     
LVEF<30%                      No         551 98% 46% 1010 98% 37% 1005 98% 23% 416 98% 24% 0.9 
                               Yes        10 2% 20% 17 2% 18% 22 2% 0% 8 2% 0%   
    
 
0% 
 
  0%     0%     0%     
shock                         0 561 100% 45% 1026 100% 36% 1027 100% 22% 424 100% 24% 0.6 
    
 
0% 
 
1 0% 0%   0%     0%     
    
 
0% 
 
  0%     0%     0%     
Preop IABP                     No       560 100% 45% 1025 100% 36% 1027 100% 22% 414 98% 24% <0.001 
                               Yes        1 0% 0% 2 0% 0%   0%   10 2% 10%   
    
 
0% 
 
  0%     0%     0%     
Non elective                  No         355 63% 44% 591 58% 39% 582 57% 24% 240 57% 27% 0.06 
                              Yes        206 37% 47% 436 42% 32% 445 43% 21% 184 43% 20%   
    
 
0% 
 
  0%     0%     0%     
Emergent/salvage                      No         559 100% 45% 1020 99% 37% 1022 100% 23% 420 99% 24% 0.6 
                              Yes        2 0% 0% 7 1% 14% 5 0% 0% 4 1% 0%   
    
 
0% 
 
  0%     0%     0%     
               
Euroscore  0-2 381 68% 46% 588 57% 35% 598 58% 24% 221 52% 32%  
  3-5 163 29% 45% 369 36% 39% 348 34% 22% 140 33% 17%  
 6 plus 17 3% 29% 70 7% 37% 81 8% 14% 63 15% 8%  
2 
  
BMI: Body Mass Index; NYHA: New York Heart Association; MI: myocardial infarction; PCI: percutaneous coronary intervention; DM: 3 
diabetes mellitus; sCr: serum creatinine; COPD: chronic obstructive pulmonary disease; CVA: cerebrovascular accident; PVD: peripheral 4 
vascular disease; AF: atrial fibrillation; NVD: number of vessel disease; LMD: left main disease; LVEF: left ventricular ejection fraction; IABP: 5 
intraaortic balloon pump6 
  
Supplementary Table 4. Short-term outcomes in 3556 matched pairs of patients operated on 7 
by Resident versus Attending Surgeon 8 
           Resident Attending  PGLMM 
N=3556 N=3556 
Re-exploration for bleeding  No 3541 99.6% 3529 99.2%   
        Yes 15 0.4% 27 0.8%   
              
Sternal wound reconstruction  No 3463 97.4% 3463 97.4%  0.07 
        Yes 93 2.6% 93 2.6%         
              
CVA No 3498 98.4% 3516 98.9% 0.07  
        Yes 58 1.6% 40 1.1%   
              
RRT No 3486 98.0% 3482 97.9% 0.58  
         Yes 70 2.0% 74 2.1%   
              
IABP No 3497 98.3% 3471 97.6% 0.03  
        Yes 59 1.7% 85 2.4%   
              
In-hospital mortality No 3527 99.2% 3520 99.0% 0.38  
        Yes 29 0.8% 36 1.0%   
GLMM: Generalized linear mixed-effects model; SW: sternal wound; CVA cerebrovascular 9 
accident; RRT: renal replacement therapy; IABP: intraaortic balloon pump.   10 
  
Figure Legend 11 
Central picture:  Survival in patients undergoing multiple arterial grafting (MAG) 12 
operated on by resident versus attending surgeon. 13 
Figure 1. Number of MAG procedures performed by resident and attending surgeon 14 
during the study period. (MAG: multiple arterial grafting) 15 
Figure 2. Standardized mean difference before and after matching (BMI: Body Mass 16 
Index; NYHA: New York Heart Association; MI: myocardial infarction; PCI: 17 
percutaneous coronary intervention; DM: diabetes mellitus; DMO: diabetes mellitus 18 
orally treated; sCr: serum creatinine; COPD: chronic obstructive pulmonary disease; 19 
CVA: cerebrovascular accident; PVD: peripheral vascular disease; AF: atrial 20 
fibrillation; NVD: number of vessel disease; LMD: left main disease; LVEF: left 21 
ventricular ejection fraction; IABP: intraaortic balloon pump) 22 
Figure 3. Survival probabilities after MAG performed by residents versus attending 23 
surgeons in the matched cohort. (MAG: multiple arterial grafting) 24 
Figure 4. Survival probabilities after MAG performed by residents stratified for stage of 25 
training (left) and supervision (right) versus attending surgeons in the matched cohort. 26 
(MAG: multiple arterial grafting)  27 
Figure 5. Survival probabilities after MAG performed by residents versus attending 28 
surgeons in the matched sample stratified for graft configuration (left), off-pump versus 29 
on pump (central) and Euroscore (right). (MAG: multiple arterial grafting; BITA: 30 
bilateral internal thoracic artery; RA: radial artery; ES: Euroscore)  31 
Supplementary Figure 1. Study flow chart. (CABG: coronary artery bypass grafting; 32 
LITA: left internal thoracic artery) 33 
  
Supplementary Figure 2. Number of non-MAG (left) and MAG (right) performed by 34 
resident and attending surgeon across different eras according to Euroscore risk class.  35 
(MAG: multiple arterial grafting) 36 
Supplementary Figure 3. Hazard function in the matched sample 37 
Supplementary Figure 4.  Survival probabilities after non-MAG procedures performed 38 
by residents versus attending surgeons in 3556 matched pairs. (MAG: multiple arterial 39 
grafting).  40 
Video 1. Off-pump multiple arterial grafting using the radial artery  41 
